Identification and Characterization of a Transcribed Distal Enhancer Involved in Cardiac Kcnh2 Regulation

Summary: The human ether-a-go-go-related gene KCNH2 encodes the voltage-gated potassium channel underlying IKr, a current critical for the repolarization phase of the cardiac action potential. Mutations in KCNH2 that cause a reduction of the repolarizing current can result in cardiac arrhythmias ass...

Full description

Bibliographic Details
Main Authors: Malou van den Boogaard, Jan Hendrik van Weerd, Amira C. Bawazeer, Ingeborg B. Hooijkaas, Harmen J.G. van de Werken, Federico Tessadori, Wouter de Laat, Phil Barnett, Jeroen Bakkers, Vincent M. Christoffels
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S221112471931040X
_version_ 1818175826751913984
author Malou van den Boogaard
Jan Hendrik van Weerd
Amira C. Bawazeer
Ingeborg B. Hooijkaas
Harmen J.G. van de Werken
Federico Tessadori
Wouter de Laat
Phil Barnett
Jeroen Bakkers
Vincent M. Christoffels
author_facet Malou van den Boogaard
Jan Hendrik van Weerd
Amira C. Bawazeer
Ingeborg B. Hooijkaas
Harmen J.G. van de Werken
Federico Tessadori
Wouter de Laat
Phil Barnett
Jeroen Bakkers
Vincent M. Christoffels
author_sort Malou van den Boogaard
collection DOAJ
description Summary: The human ether-a-go-go-related gene KCNH2 encodes the voltage-gated potassium channel underlying IKr, a current critical for the repolarization phase of the cardiac action potential. Mutations in KCNH2 that cause a reduction of the repolarizing current can result in cardiac arrhythmias associated with long-QT syndrome. Here, we investigate the regulation of KCNH2 and identify multiple active enhancers. A transcribed enhancer ∼85 kbp downstream of Kcnh2 physically contacts the promoters of two Kcnh2 isoforms in a cardiac-specific manner in vivo. Knockdown of its ncRNA transcript results in reduced expression of Kcnh2b and two neighboring mRNAs, Nos3 and Abcb8, in vitro. Genomic deletion of the enhancer, including the ncRNA transcription start site, from the mouse genome causes a modest downregulation of both Kcnh2a and Kcnh2b in the ventricles. These findings establish that the regulation of Kcnh2a and Kcnh2b is governed by a complex regulatory landscape that involves multiple partially redundantly acting enhancers. : KCNH2 encodes a potassium channel critical for cardiac repolarization. Van den Boogaard et al. identified a transcribed cardiac-specific enhancer physically contacting Kcnh2. Genomic deletion by CRISPR/Cas9 caused a modest decrease in ventricular Kcnh2a and Kcnh2b expression, demonstrating the complexity of the regulatory landscape regulating Kcnh2 expression. Keywords: Kcnh2, hERG, LQTS, enhancer, transcriptional regulation, regulatory element, CRISPR genome editing, chromatin conformation, ncRNA
first_indexed 2024-12-11T20:06:28Z
format Article
id doaj.art-f23e46c627da422ab766f3b9dde3a0a8
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-11T20:06:28Z
publishDate 2019-09-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-f23e46c627da422ab766f3b9dde3a0a82022-12-22T00:52:24ZengElsevierCell Reports2211-12472019-09-01281027042714.e5Identification and Characterization of a Transcribed Distal Enhancer Involved in Cardiac Kcnh2 RegulationMalou van den Boogaard0Jan Hendrik van Weerd1Amira C. Bawazeer2Ingeborg B. Hooijkaas3Harmen J.G. van de Werken4Federico Tessadori5Wouter de Laat6Phil Barnett7Jeroen Bakkers8Vincent M. Christoffels9Amsterdam UMC, University of Amsterdam, Department of Medical Biology, Amsterdam Cardiovascular Sciences, 1105AZ Amsterdam, the NetherlandsAmsterdam UMC, University of Amsterdam, Department of Medical Biology, Amsterdam Cardiovascular Sciences, 1105AZ Amsterdam, the NetherlandsAmsterdam UMC, University of Amsterdam, Department of Medical Biology, Amsterdam Cardiovascular Sciences, 1105AZ Amsterdam, the NetherlandsAmsterdam UMC, University of Amsterdam, Department of Medical Biology, Amsterdam Cardiovascular Sciences, 1105AZ Amsterdam, the NetherlandsCancer Computational Biology Center, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, the Netherlands; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, the Netherlands; Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the NetherlandsHubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the NetherlandsHubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the NetherlandsAmsterdam UMC, University of Amsterdam, Department of Medical Biology, Amsterdam Cardiovascular Sciences, 1105AZ Amsterdam, the NetherlandsHubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the NetherlandsAmsterdam UMC, University of Amsterdam, Department of Medical Biology, Amsterdam Cardiovascular Sciences, 1105AZ Amsterdam, the Netherlands; Corresponding authorSummary: The human ether-a-go-go-related gene KCNH2 encodes the voltage-gated potassium channel underlying IKr, a current critical for the repolarization phase of the cardiac action potential. Mutations in KCNH2 that cause a reduction of the repolarizing current can result in cardiac arrhythmias associated with long-QT syndrome. Here, we investigate the regulation of KCNH2 and identify multiple active enhancers. A transcribed enhancer ∼85 kbp downstream of Kcnh2 physically contacts the promoters of two Kcnh2 isoforms in a cardiac-specific manner in vivo. Knockdown of its ncRNA transcript results in reduced expression of Kcnh2b and two neighboring mRNAs, Nos3 and Abcb8, in vitro. Genomic deletion of the enhancer, including the ncRNA transcription start site, from the mouse genome causes a modest downregulation of both Kcnh2a and Kcnh2b in the ventricles. These findings establish that the regulation of Kcnh2a and Kcnh2b is governed by a complex regulatory landscape that involves multiple partially redundantly acting enhancers. : KCNH2 encodes a potassium channel critical for cardiac repolarization. Van den Boogaard et al. identified a transcribed cardiac-specific enhancer physically contacting Kcnh2. Genomic deletion by CRISPR/Cas9 caused a modest decrease in ventricular Kcnh2a and Kcnh2b expression, demonstrating the complexity of the regulatory landscape regulating Kcnh2 expression. Keywords: Kcnh2, hERG, LQTS, enhancer, transcriptional regulation, regulatory element, CRISPR genome editing, chromatin conformation, ncRNAhttp://www.sciencedirect.com/science/article/pii/S221112471931040X
spellingShingle Malou van den Boogaard
Jan Hendrik van Weerd
Amira C. Bawazeer
Ingeborg B. Hooijkaas
Harmen J.G. van de Werken
Federico Tessadori
Wouter de Laat
Phil Barnett
Jeroen Bakkers
Vincent M. Christoffels
Identification and Characterization of a Transcribed Distal Enhancer Involved in Cardiac Kcnh2 Regulation
Cell Reports
title Identification and Characterization of a Transcribed Distal Enhancer Involved in Cardiac Kcnh2 Regulation
title_full Identification and Characterization of a Transcribed Distal Enhancer Involved in Cardiac Kcnh2 Regulation
title_fullStr Identification and Characterization of a Transcribed Distal Enhancer Involved in Cardiac Kcnh2 Regulation
title_full_unstemmed Identification and Characterization of a Transcribed Distal Enhancer Involved in Cardiac Kcnh2 Regulation
title_short Identification and Characterization of a Transcribed Distal Enhancer Involved in Cardiac Kcnh2 Regulation
title_sort identification and characterization of a transcribed distal enhancer involved in cardiac kcnh2 regulation
url http://www.sciencedirect.com/science/article/pii/S221112471931040X
work_keys_str_mv AT malouvandenboogaard identificationandcharacterizationofatranscribeddistalenhancerinvolvedincardiackcnh2regulation
AT janhendrikvanweerd identificationandcharacterizationofatranscribeddistalenhancerinvolvedincardiackcnh2regulation
AT amiracbawazeer identificationandcharacterizationofatranscribeddistalenhancerinvolvedincardiackcnh2regulation
AT ingeborgbhooijkaas identificationandcharacterizationofatranscribeddistalenhancerinvolvedincardiackcnh2regulation
AT harmenjgvandewerken identificationandcharacterizationofatranscribeddistalenhancerinvolvedincardiackcnh2regulation
AT federicotessadori identificationandcharacterizationofatranscribeddistalenhancerinvolvedincardiackcnh2regulation
AT wouterdelaat identificationandcharacterizationofatranscribeddistalenhancerinvolvedincardiackcnh2regulation
AT philbarnett identificationandcharacterizationofatranscribeddistalenhancerinvolvedincardiackcnh2regulation
AT jeroenbakkers identificationandcharacterizationofatranscribeddistalenhancerinvolvedincardiackcnh2regulation
AT vincentmchristoffels identificationandcharacterizationofatranscribeddistalenhancerinvolvedincardiackcnh2regulation